Skip to content

Company information lookup

ACRUX LIMITED (ACR)

A pooled development fund that invests in pharmaceutical businesses developing new products involving the delivery of pharmaceuticals via the skin.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
ACR 1.280 -2.66% 1.255 1.290 1.300 1.300 1.220 973,224

ACRUX LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code ACR
Securities
Official Listing Date 29 September, 2004
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.acrux.com.au
Registered Office Address 103-113 Stanley Street, WEST MELBOURNE, VIC, AUSTRALIA, 3003
Head Office Telephone (03) 8379 0100
Head Office Fax (03) 8379 0101
Share Registry LINK MARKET SERVICES LIMITED
LEVEL 1, 333 COLLINS STREET, MELBOURNE, VIC, AUSTRALIA, 3000
Share Registry Telephone 1300 554 474
Directors / Senior Management
Mr Ross Dobinson (Chairman)
Mr Ross Barrow (Non Exec. Director)
Mr Timothy Oldham (Non Exec. Director)
Mr Bruce Parncutt (Non Exec. Director)
Ms Sharon Papworth (CFO)
Company Secretary Ms Sharon Papworth
Principal Activities A pooled development fund that invests in pharmaceutical businesses developing new products involving the delivery of pharmaceuticals via the skin.

ACRUX LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
27/11/2014   2014 AGM Results of Meeting 1 PDF
27/11/2014   2014 AGM Chariman's Address and Presentation 24 PDF
26/11/2014   Change in substantial holding 6 PDF
24/11/2014   European Medicines Agency Testosterone update 5 PDF
12/11/2014   Investor Presentation 22 PDF
24/10/2014   2014 Annual Report 64 PDF
24/10/2014   Notice of Annual General Meeting and Proxy Form 7 PDF
24/10/2014 asterix Axiron Net Sales, quarter to 30 September 2014 1 PDF
21/10/2014   Ceasing to be a substantial holder from AMP 8 PDF
15/10/2014   Change in substantial holding 5 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
28 Nov 2014 1.280 -2.66% 1.300 1.220 973,224
27 Nov 2014 1.315 -0.75% 1.370 1.290 679,827
26 Nov 2014 1.325 8.61% 1.370 1.200 1,783,317
25 Nov 2014 1.220 -9.29% 1.420 1.210 5,040,497
24 Nov 2014 1.345 5.08% 1.450 1.185 3,289,432

* Volume of shares shown represents only those shares traded on ASX.

ACRUX LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

Code Div Amount Ex Div Date Record Date Date Payable % Franked Type Further Information
ACR 8c 03/09/2013 09/09/2013 23/09/2013 0% Final UNFRANKED NIL CFI
ACR 12c 25/02/2014 03/03/2014 20/03/2014 0% Interim UNFRANKED NIL CFI SPECIAL
ACR 8c 04/09/2014 08/09/2014 22/09/2014 100% Final 8C FRANKED @ 30%

Exchange Traded Options

No Exchange Traded Options are available over the security ACR

Warrants & Structured Products

No warrants & Structured Products are available over the security ACR